Silexion Therapeutics Corp. Revenue 2023–2025
Silexion Therapeutics Corp. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Silexion Therapeutics Corp. revenue for the quarter ending March 31, 2026 was 32000, a 1500.00% increase year-over-year.
- Silexion Therapeutics Corp. revenue for the twelve months ending March 31, 2026 was 117000.
- Silexion Therapeutics Corp. annual revenue for 2025 was 155000, a 453.57% increase from 2024.
- Silexion Therapeutics Corp. annual revenue for 2024 was 28000, a 81.70% decrease from 2023.
- Silexion Therapeutics Corp. annual revenue for 2023 was 153000.
Silexion Therapeutics Corp. (SLXN) — Frequently Asked Questions
Silexion Therapeutics Corp. (SLXN) is a publicly traded US company. It has a market capitalization of $4M. In fiscal 2025 it reported revenue of $155,000 and net income of -$12M. Explore SLXN's stock price, financial statements, earnings history, margins and key ratios below.
What is Silexion Therapeutics Corp.'s market cap?
Silexion Therapeutics Corp. (SLXN) has a market capitalization of $4M.
What is the SLXN stock price?
SLXN trades at $3.06 (-26.62% on the day).
How much revenue does Silexion Therapeutics Corp. make?
Silexion Therapeutics Corp. reported revenue of $155,000 in fiscal 2025.
Is SLXN profitable?
In fiscal 2025, Silexion Therapeutics Corp. reported net income of -$12M.